Ductal Adenocarcinoma of the Prostate- from Endometriod Cancer to TodayBhawanie Koonj Beharry1*, Ania Sliwinski1, Darren Ow1, Kiran Manya1, David Wetherell1, Mahesha Weerakoon1, Damien Bolton1 and Nathan Lawrentschuk2
- *Corresponding Author:
- Dr. Bhawanie Koonj Beharry
Room 8244, Level 8, Harold-Stoked Building
Austin Hospital, 145 Studley Road, Heidelberg
Victoria 3141, Australia
E-mail: [email protected]
Received date: June 21, 2013; Accepted date: July 23, 2013; Published date: July 25, 2013
Citation: Beharry BK, Sliwinski A, Ow D, Manya K, Wetherell D, et al. (2013) Ductal Adenocarcinoma of the Prostate- from Endometriod Cancer to Today. J Cytol Histol 4:180. doi:10.4172/2157-7099.1000180
Copyright: © 2013 Beharry BK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Ductal adenocarcinoma of the prostate is a rare variety of the common acinar adenocarcinoma. It usually presents
with obstructive symptoms and at cystoscopy is seen as an exophytic lesion at the area of the verumontanum. It
accounts for less than 1% of all prostate cancers.
We present the case of a 53 year old male who was diagnosed with ductal adenocarcinoma of the prostate
after undergoing elective transurethral resection of the prostate. Immunohistochemistry confirmed the nature of the
tumour. The patient underwent a radical prostatectomy, however histopathology showed extensive extraprostatic
Men with prostatic ductal adenocarcinoma have a worse prognosis than men with prostatic acinar adenocarcinoma
thus, early diagnosis and aggressive management is indicated, even with low-volume metastatic disease.